Molecular biology of gastric cancer

Cervantes, A; Rodríguez Braun, E; Pérez Fidalgo, A; Chirivella González, I.
Clin. transl. oncol. (Print) ; 9(4): 208-215, abr. 2007. tab, ilus
Artigo em Inglês | IBECS (Espanha) | ID: ibc-123294

Documentos relacionados

  1. High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer.
  2. Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1.
  3. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
  4. NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.
  5. Personalized therapeutic strategies in HER2-driven gastric cancer.
  6. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
  7. Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer.
  8. Molecular biology of gastric cancer.
  9. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
  10. Tyrosine kinases and gastric cancer.